In the latest trading session, 0.48 million shares of the Oscar Health Inc (NYSE:OSCR) were traded, and its beta was 1.58. Most recently the company’s share price was $21.90, and it changed around $0.29 or 1.36% from the last close, which brings the market valuation of the company to $5.30B. OSCR currently trades at a discount to its 52-week high of $23.44, offering almost -7.03% off that amount. The share price’s 52-week low was $4.72, which indicates that the current value has risen by an impressive 78.45% since then. We note from Oscar Health Inc’s average daily trading volume that its 10-day average is 3.37 million shares, with the 3-month average coming to 3.09 million.

Oscar Health Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.67. If we narrow it down even further, the data shows that 0 out of 6 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 1 recommended OSCR as a Hold, whereas 4 deemed it a Buy, and 0 rated it as Underweight. Oscar Health Inc is expected to report earnings per share of -0.17 for the current quarter.

Oscar Health Inc (NYSE:OSCR) trade information

Instantly OSCR has showed a green trend with a performance of 1.36% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 22.28 on recent trading dayincreased the stock’s daily price by 1.71%. The company’s shares are currently up 139.38% year-to-date, but still up 25.37% over the last five days. On the other hand, Oscar Health Inc (NYSE:OSCR) is 21.35% up in the 30-day period. We can see from the shorts that 17.86 million shares have been sold at a short interest cover period of 6.38 day(s).

The consensus price target as assigned by Wall Street analysts is $21, which translates to bulls needing to decrease their stock price by -4.29% from its current value. Analyst projections state that OSCR is forecast to be at a low of $5 and a high of $28.

Oscar Health Inc (OSCR) estimates and forecasts

Oscar Health Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 58.14 percent over the past six months and at a 100.82% annual growth rate that is well above the industry average of 10.90%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will gain 41.40% in revenue this quarter, and will report an increase of 13.60% in the next quarter. The year-over-year growth rate is expected to be 54.20%, up from the previous year.

Consensus estimates provided by 5 financial analysts predict the company will bring in an average of 2.33B in revenue for the current quarter. 5 analysts expect Oscar Health Inc to make 2.35B in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 1.44B and 1.43B respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 61.90%. Forecasts for the next quarter put sales growth at 63.90%.

Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -2.85%.

OSCR Dividends

Oscar Health Inc’s next quarterly earnings report is expected to be released on 2024-Nov-05.

Oscar Health Inc (NYSE:OSCR)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 2.79% of Oscar Health Inc shares, and 84.59% of them are in the hands of institutional investors. The stock currently has a share float of 87.02%. Oscar Health Inc stock is held by 349.0 institutions, with VANGUARD GROUP INC being the largest institutional investor. By 2024-06-30, it held 7.5114% of the shares, which is about 17.38 million shares worth $275.03 million.

BLACKROCK INC., with 6.1246% or 14.18 million shares worth $224.25 million as of 2024-06-30, holds the second largest percentage of outstanding shares.